The largest insider buy on today's list is a Form 4 filing by Column Group, which reported the purchase of approximately $5.8 million in NGM Biopharmaceuticals $NGM.
Kevin Riley, the CEO and president of First Interstate BancSystem $FIBK,...
Key Takeaway: Investor moods will change as prices fluctuate but they seemed to follow word with deed in May. The AAII asset allocation survey showed them lightening up (perhaps only...
Longtime readers know how much we love new monthly candlesticks. They force us to zoom out from the day-to-day noise and focus on what's really taking place.
We play with the cards we are dealt. There is nothing else we can do. We cannot employ willpower to create market conditions into being the way we'd prefer them to be. They are what they are, it is what it is. So we work with what we've got.
The largest insider buy on today’s list comes in a Form 4 filing by ValueAct Capital.
It reveals an additional purchase of roughly $7.8 million in Insight Enterprises $NSIT, as ValueAct continues to increase its position in the tech stock.